VITEK PROPLAST

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-11-13 for VITEK PROPLAST manufactured by Unk.

Event Text Entries

[127141237] The pt had the vitek proplast implant and was at (b)(6) in (b)(6) 2018 (5' 6 1/2"). She was unable to find anymore to help her treat her pain. Her blood pressure was at 248/123 due to pain. She had 38 facial and jaw surgeries to try to fix the proplast damage. She also had 32 others to fix her crumbling body from the teflon fragments. She had horrendous pain throughout her face, jaw and body; 13 of the proplast implants broke / ruptured inside her. Her pain dr abandoned her as he said she was too complicated. He cut her off all pain and muscle relaxers. She was unable to eat as she developed strictures in her esophagus. Water would not go down either. She would have her throat dilated every few months. Her hands were not able to be used as she developed severe arthritis everywhere. Proplast ruined her life. She had the first surgery at the age of (b)(6) and she died (b)(6).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5081187
MDR Report Key8068997
Date Received2018-11-13
Date of Report2018-11-06
Date of Event1982-01-01
Date Added to Maude2018-11-14
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationUNKNOWN
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVITEK PROPLAST
Generic NameIMPLANT, MALAR
Product CodeLZK
Date Received2018-11-13
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerUNK
Manufacturer AddressUNK UNK


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2018-11-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.